The CLSTN1 Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the CLSTN1 gene in a B lymphocyte context. This product comprises a heterogeneous pool of Raji cells carrying targeted disruptions at the CLSTN1 genomic locus, enabling researchers to interrogate the functional consequences of CLSTN1 depletion across a diverse cellular background. The polyclonal format preserves genetic variability inherent to the knockout process, providing a robust model for assessing gene function without the clonal artifacts often associated with single-cell-derived lines. As a polyclonal population, these cells are ideally suited for applications where pooled analysis captures a broad spectrum of phenotypic outcomes, such as signaling pathway interrogation, adhesion assays, and transcriptomic profiling.
Derived from a human Burkitt lymphoma biopsy, the Raji host cell line is a well-characterized Epstein-Barr virus (EBV)-positive B lymphoblastoid line that grows in suspension. Raji cells serve as a foundational model in B cell biology, widely employed to dissect mechanisms of lymphomagenesis, EBV latency, and lymphocyte signaling. Their suspension growth habit facilitates large-scale culture and high-throughput experimentation, while their B lineage identity provides a physiologically relevant platform for studying antigen presentation, immunoglobulin expression, and oncogenic transformation. The retention of key B cell surface markers and signaling molecules, including CD19, CD20, and surface IgM, ensures compatibility with standard immunophenotyping and functional assays. The EBV-positive status of Raji cells also permits investigation of viral-host interactions, making this line a versatile tool for infectious disease and immuno-oncology research.
CLSTN1, or calsyntenin-1, encodes a postsynaptic transmembrane protein that modulates calcium signaling, cell adhesion, and intracellular trafficking. In this cellular context, CLSTN1 interacts with amyloid precursor protein (APP) and the adaptor protein APBA2 (X11L) to form a tripartite complex that regulates APP processing and subsequent amyloid-beta (A??) production. The protein is activated by neuronal activity and calcium influx, with upstream regulators including CREB, REST, and Wnt signaling components. CLSTN1 functions downstream of these inputs to influence downstream targets such as kinesin-1 motor protein KIF5C, thereby controlling vesicular transport and synaptic plasticity effectors. Additionally, CLSTN1 engages with ??-catenin, bridging calcium and Wnt pathways, and interacts with family members CLSTN2 and CLSTN3, as well as kinesin light chain KLC1, highlighting its role in coordinating adhesion and trafficking networks.
Although CLSTN1 is primarily characterized in neuronal systems, its functions in cell adhesion and signaling are likely relevant in B lymphocytes, where dynamic cell-cell interactions and intracellular trafficking underpin immune responses. The Raji cell model offers a unique opportunity to explore non-neuronal roles of CLSTN1, particularly in the context of APP metabolism and endocytic recycling, which are operative in lymphocytes. By disrupting CLSTN1 in an EBV-immortalized B cell line, researchers can investigate how loss of this gene impacts lymphocyte adhesion to antigen-presenting cells, calcium-dependent signaling cascades, and ??-catenin-mediated transcriptional programs. Moreover, since Raji cells express endogenous APP, this model enables the study of CLSTN1??s influence on APP cleavage and A??-like peptide generation outside the brain, contributing to a broader understanding of Alzheimer’s disease-related mechanisms in peripheral cells.
Typical research applications for CLSTN1 Knockout Raji Polyclonal Cells encompass a wide array of molecular and cellular biology techniques. Users can employ Western blotting and RT-qPCR to confirm target gene depletion and quantify transcript level changes in downstream effectors such as KIF5C or ??-catenin. Flow cytometry enables assessment of surface adhesion molecule expression and cell viability, while calcium imaging assays can reveal alterations in calcium dynamics upon CLSTN1 loss. Co-immunoprecipitation studies facilitate mapping of protein interaction networks involving APP, APBA2, and KLC1, and cell adhesion assays provide functional readouts of the knockout phenotype. Transcriptomic analyses via RNA-seq can uncover global gene expression changes linked to CLSTN1-dependent pathways. These cells thus support investigations into B cell biology, Alzheimer’s disease mechanisms, and calcium signaling, providing a versatile loss-of-function platform. For further information, please contact Ascent Research.
